Filing Impact
Filing Sentiment
Form Type
144
Quest Diagnostics Inc
Aug 26, 2025
Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan
Aug 25, 2025
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
Aug 13, 2025
Quest Diagnostics Declares Quarterly Cash Dividend
Aug 21, 2025
[144] Quest Diagnostics Inc. SEC Filing
Aug 19, 2025
[144] Quest Diagnostics Inc. SEC Filing
20.15B
111.32M
0.4%
99.13%
4.24%
Diagnostics & Research
Services-medical Laboratories
United States
SECAUCUS